Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 14;10(8):1675.
doi: 10.3390/jcm10081675.

Management of Implantable Cardioverter-Defibrillators during Pregnancy-A Systematic Review

Albert Topf  1 , Nina Bacher  1 , Kristen Kopp  1 , Moritz Mirna  1 , Robert Larbig  2   3 , Mathias C Brandt  1 , Johannes Kraus  1 , Uta C Hoppe  1 , Lukas J Motloch  1 , Michael Lichtenauer  1
Affiliations
Review

Management of Implantable Cardioverter-Defibrillators during Pregnancy-A Systematic Review

Albert Topf et al. J Clin Med. .

Abstract

Background: With the advent of implantable cardioverter-defibrillator (ICD) technology in recent decades, patients with inherited or congenital cardiomyopathy have a greater chance of survival into adulthood. Women with ICDs in this group are now more likely to reach reproductive age. However, pregnancy represents a challenge for clinicians, as no guidelines for the treatment of pregnant women with an ICD are currently available.

Methods: To analyze this issue, we performed a systematic screening of the literature using the keywords: pregnancy with ICD, lead fracture in pregnancy, lead thrombi in pregnancy, ventricular tachycardia in pregnancy, inappropriate shocks in pregnancy, ICD discharge in pregnancy and ICD shock in pregnancy. Of 1101 publications found, 27 publications were eligible for further analysis (four retrospective trials and 23 case reports).

Results: According to physiological changes in pregnancy, resulting in an increase in heart rate and cardiac output, a vulnerability for malignant arrhythmias and device-related complications in ICD carriers might be suspected. While the literature is limited on this issue, maternal complications including arrhythmia burden with following ICD therapies, thromboembolic events and lead complications as well as inappropriate shock therapy have been reported. According to the limited available studies, associated risk seems not to be more frequent than in the general population and depends on the underlying cardiac pathology. Furthermore, worsening of heart failure and related cardiovascular disease have been reported with associated risk of preterm delivery. These observations are exaggerated by restricted applications of diagnostics and treatment due to the risk of fetal harm in this population.

Conclusions: Due to limited data on management of ICDs during pregnancy, further scientific investigations are required. Consequently, careful risk assessment with individual risk evaluation and close follow ups with interdisciplinary treatment are recommended in pregnant ICD carriers.

Keywords: ICD; cardiomyopathy; management; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart outlining the protocol adopted in this systematic review for literature selection.
See this image and copyright information in PMC

References

    1. Hollier L.M., James M.D., Martin N., Jr., Heidi M.D., Connolly M.D., Turrentine M., Afshan M.D. ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease. Obstet. Gynecol. 2019;133:e320–e356. - PubMed
    1. Ishikawa T. Implantable cardioverter defibrillator therapy during pregnancy—Is it safe and effective? Circ. J. 2013;77:1146–1147. doi: 10.1253/circj.CJ-13-0293. - DOI - PubMed
    1. Goldstein S., Ward C., Al-Khatib S. The Use of Implantable Cardioverter-defibrillators in the Prevention of Sudden Cardiac Death: A Focus on Congenital Heart Disease and Inherited Arrhythmia Syndromes. J. Innov. Card. Rhythm Manag. 2018;9:2996–3005. doi: 10.19102/icrm.2018.090103. - DOI - PMC - PubMed
    1. Phillips S., Pirics M. Congenital Heart Disease and Reproductive Risk: An Overview for Obstetricians, Cardiologists, and Primary Care Providers. Methodist DeBakey Cardiovasc. J. 2017;13:238–242. - PMC - PubMed
    1. Ertekin E., van Hagen I.M., Salam A.M., Ruys T.P., Johnson M.R., Popelova J., Parsonage W.A., Ashour Z., Shotan A., Oliver J.M., et al. Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology. Int. J. Cardiol. 2016;220:131–136. doi: 10.1016/j.ijcard.2016.06.061. - DOI - PubMed

LinkOut - more resources